-
00:30
1.
index 1
-
00:26
2.
Breast Cancer
-
00:32
3.
Triple-Negative Breast Cancer(TNBC)
-
00:36
4.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:17
5.
Circular RNA (CircRNA)
-
00:26
6.
Functions of circRNA
-
00:31
7.
MicroRNA (miRNA)
-
00:40
8.
Aim
-
00:59
9.
The expression and prognostic significance of circWAC in TNBC
-
01:12
10.
Features of circWAC
-
00:42
11.
CircWAC was mainly distributed in the cytoplasm
-
00:38
12.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:43
13.
CircWAC decrease chemosensitivity to PTX in TNBC
-
01:11
14.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:39
15.
CircWAC acts as a sponge of miR-142 in TNBC
-
01:31
16.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:29
17.
CircWAC acts as a sponge of miR-142 in TNBC
-
01:04
18.
CircWAC regulates PTX resistance by targeting miR-142
-
00:28
19.
CircWAC regulates PTX resistance by targeting miR-142
-
01:12
20.
WWP1 is the direct target gene of miR-142
-
00:58
21.
WWP1 is the direct target gene of miR-142
-
01:28
22.
WWP1 is the direct target gene of miR-142
-
00:30
23.
The expression and prognostic significance of circWAC in TNBC
-
01:22
24.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:33
25.
Conclusion
-
01:02
26.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:22
27.
Thank you for listening.
-
00:08
28.
Model for WWP1-mediated PTEN K27-linked polyubiquitination in tumor development and progression
-
00:00
29.
PI3K/AKT pathway
-
00:03
30.
Slide 29
-
00:00
31.
CircWAC had no obvious relationship with cell metastasis and invasion
-
00:00
32.
Thank you for listening.
-
00:00
33.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:00
34.
Conclusion
-
00:00
35.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
36.
The expression and prognostic significance of circWAC in TNBC
-
00:22
37.
WWP1 is the direct target gene of miR-142
-
00:06
38.
WWP1 is the direct target gene of miR-142
-
01:57
39.
WWP1 is the direct target gene of miR-142
-
00:02
40.
Model for WWP1-mediated PTEN K27-linked polyubiquitination in tumor development and progression
-
00:00
41.
PI3K/AKT pathway
-
00:00
42.
Slide 29
-
00:00
43.
CircWAC had no obvious relationship with cell metastasis and invasion
-
00:00
44.
Thank you for listening.
-
00:00
45.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:00
46.
Conclusion
-
00:00
47.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
48.
The expression and prognostic significance of circWAC in TNBC
-
00:00
49.
WWP1 is the direct target gene of miR-142
-
00:00
50.
WWP1 is the direct target gene of miR-142
-
00:00
51.
WWP1 is the direct target gene of miR-142
-
00:00
52.
CircWAC regulates PTX resistance by targeting miR-142
-
00:03
53.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
54.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
55.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
56.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:33
57.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
58.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
59.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
60.
CircWAC was mainly distributed in the cytoplasm
-
00:00
61.
Features of circWAC
-
00:00
62.
The expression and prognostic significance of circWAC in TNBC
-
00:00
63.
Aim
-
00:00
64.
MicroRNA (miRNA)
-
00:00
65.
Functions of circRNA
-
00:00
66.
Circular RNA (CircRNA)
-
00:00
67.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:32
68.
Triple-Negative Breast Cancer(TNBC)
-
00:29
69.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:02
70.
Circular RNA (CircRNA)
-
00:08
71.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:04
72.
Circular RNA (CircRNA)
-
01:10
73.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
74.
Circular RNA (CircRNA)
-
00:03
75.
Functions of circRNA
-
00:01
76.
Circular RNA (CircRNA)
-
00:00
77.
Functions of circRNA
-
00:07
78.
MicroRNA (miRNA)
-
00:21
79.
Functions of circRNA
-
00:00
80.
MicroRNA (miRNA)
-
01:03
81.
Aim
-
00:04
82.
The expression and prognostic significance of circWAC in TNBC
-
00:00
83.
Features of circWAC
-
00:00
84.
CircWAC was mainly distributed in the cytoplasm
-
00:00
85.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:01
86.
CircWAC was mainly distributed in the cytoplasm
-
00:21
87.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
88.
CircWAC was mainly distributed in the cytoplasm
-
00:00
89.
Features of circWAC
-
00:04
90.
The expression and prognostic significance of circWAC in TNBC
-
00:28
91.
Features of circWAC
-
00:50
92.
CircWAC was mainly distributed in the cytoplasm
-
00:00
93.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
94.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:14
95.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
96.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
97.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
98.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
99.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
100.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
101.
WWP1 is the direct target gene of miR-142
-
00:00
102.
WWP1 is the direct target gene of miR-142
-
00:01
103.
WWP1 is the direct target gene of miR-142
-
00:24
104.
WWP1 is the direct target gene of miR-142
-
00:09
105.
WWP1 is the direct target gene of miR-142
-
00:00
106.
The expression and prognostic significance of circWAC in TNBC
-
00:00
107.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:44
108.
Conclusion
-
01:20
109.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:00
110.
Conclusion
-
00:00
111.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
112.
The expression and prognostic significance of circWAC in TNBC
-
00:00
113.
WWP1 is the direct target gene of miR-142
-
00:00
114.
WWP1 is the direct target gene of miR-142
-
00:00
115.
WWP1 is the direct target gene of miR-142
-
00:00
116.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
117.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
118.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
119.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
120.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
121.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
122.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
123.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
124.
CircWAC was mainly distributed in the cytoplasm
-
00:00
125.
Features of circWAC
-
00:00
126.
The expression and prognostic significance of circWAC in TNBC
-
00:00
127.
Aim
-
00:00
128.
MicroRNA (miRNA)
-
00:00
129.
Functions of circRNA
-
00:00
130.
Circular RNA (CircRNA)
-
00:00
131.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
132.
Triple-Negative Breast Cancer(TNBC)
-
00:53
133.
Breast Cancer
-
00:01
134.
Triple-Negative Breast Cancer(TNBC)
-
00:03
135.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:02
136.
Circular RNA (CircRNA)
-
00:00
137.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:04
138.
Triple-Negative Breast Cancer(TNBC)
-
00:25
139.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:09
140.
Triple-Negative Breast Cancer(TNBC)
-
00:00
141.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:07
142.
Circular RNA (CircRNA)
-
01:37
143.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
144.
Circular RNA (CircRNA)
-
00:01
145.
Functions of circRNA
-
00:00
146.
Circular RNA (CircRNA)
-
00:04
147.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
148.
Circular RNA (CircRNA)
-
00:02
149.
Functions of circRNA
-
00:00
150.
MicroRNA (miRNA)
-
00:12
151.
Functions of circRNA
-
00:00
152.
Circular RNA (CircRNA)
-
00:13
153.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
154.
Circular RNA (CircRNA)
-
00:00
155.
Functions of circRNA
-
00:01
156.
MicroRNA (miRNA)
-
00:02
157.
Aim
-
00:05
158.
MicroRNA (miRNA)
-
00:00
159.
Functions of circRNA
-
00:00
160.
Circular RNA (CircRNA)
-
00:54
161.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
01:34
162.
Triple-Negative Breast Cancer(TNBC)
-
00:07
163.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:15
164.
Circular RNA (CircRNA)
-
00:00
165.
Functions of circRNA
-
00:00
166.
MicroRNA (miRNA)
-
01:18
167.
Aim
-
00:08
168.
The expression and prognostic significance of circWAC in TNBC
-
01:19
169.
Features of circWAC
-
00:00
170.
CircWAC was mainly distributed in the cytoplasm
-
00:00
171.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
172.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:31
173.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
174.
CircWAC was mainly distributed in the cytoplasm
-
00:00
175.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
176.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
177.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
178.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
179.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
180.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
181.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
182.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
183.
WWP1 is the direct target gene of miR-142
-
00:00
184.
WWP1 is the direct target gene of miR-142
-
00:00
185.
WWP1 is the direct target gene of miR-142
-
00:00
186.
The expression and prognostic significance of circWAC in TNBC
-
00:00
187.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
188.
Conclusion
-
00:53
189.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:00
190.
Conclusion
-
00:00
191.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
192.
The expression and prognostic significance of circWAC in TNBC
-
00:00
193.
WWP1 is the direct target gene of miR-142
-
00:00
194.
WWP1 is the direct target gene of miR-142
-
00:00
195.
WWP1 is the direct target gene of miR-142
-
00:00
196.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
197.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
198.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
199.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
200.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:05
201.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:03
202.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:01
203.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:03
204.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:18
205.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
206.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
207.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
208.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
209.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
210.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
211.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
212.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
213.
CircWAC regulates PTX resistance by targeting miR-142
-
00:02
214.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
215.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
216.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
217.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
218.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:30
219.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
220.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
221.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
222.
CircWAC was mainly distributed in the cytoplasm
-
00:00
223.
Features of circWAC
-
00:00
224.
The expression and prognostic significance of circWAC in TNBC
-
00:01
225.
Aim
-
00:12
226.
MicroRNA (miRNA)
-
00:00
227.
Functions of circRNA
-
00:00
228.
Circular RNA (CircRNA)
-
01:16
229.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
00:00
230.
Triple-Negative Breast Cancer(TNBC)
-
00:00
231.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
-
01:28
232.
Circular RNA (CircRNA)
-
00:01
233.
Functions of circRNA
-
00:00
234.
MicroRNA (miRNA)
-
00:00
235.
Aim
-
00:00
236.
The expression and prognostic significance of circWAC in TNBC
-
00:00
237.
Features of circWAC
-
00:00
238.
CircWAC was mainly distributed in the cytoplasm
-
00:00
239.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
240.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
241.
CircWAC decrease chemosensitivity to PTX in TNBC
-
00:00
242.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
243.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
244.
CircWAC acts as a sponge of miR-142 in TNBC
-
00:00
245.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
246.
CircWAC regulates PTX resistance by targeting miR-142
-
00:00
247.
WWP1 is the direct target gene of miR-142
-
00:00
248.
WWP1 is the direct target gene of miR-142
-
00:00
249.
WWP1 is the direct target gene of miR-142
-
00:00
250.
The expression and prognostic significance of circWAC in TNBC
-
00:00
251.
Inhibition of circWAC increases sensitivity to PTX in vivo
-
00:00
252.
Conclusion
-
06:17
253.
Pros: They clearly discovered the network between circWAC and miR-142 using tissue samples from TNBC patients and databases. This research included an in vivo experiment to demonstrate how circWAC inhibition can improve chemosensitivity to PTX.They discov
-
00:42
254.
** after 20221101 林俐妤seminar.pptx